SCHEMBL4770873

SCHEMBL4770873

CCCn1c(=O)c([N+](=O)[O-])c(/C=C/c2cnn(-c3ccccc3)c2)n(CC)c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.45
ADORA2B P29275 3/20 0.45
ADORA1 P30542 3/20 0.45
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 3/20 0.38
POLB P06746 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
MITF O75030 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
AGTR1 P30556 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TLR9 Q9NR96 1/20 0.38
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4770893 1.00 ADORA2A (0.45) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4792653 0.94 NPC1 (0.44) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4792657 0.94 NPC1 (0.44) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4767911 0.91 NCOA1 (0.42) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4767902 0.91 NCOA1 (0.42) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4765287 0.90 ADORA2A (0.42) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4766274 0.86 NPC1 (0.41) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4765291 0.86 NPC1 (0.40) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4762619 0.86 SMN1; SMN2 (0.41) ADORA2AADORA2BADORA1NPC1RAB9A
SCHEMBL4762614 0.86 SMN1; SMN2 (0.41) ADORA2AADORA2BADORA1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed